Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Aster DM Quality Care Ltd (ASTERDM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540975 NSE: ASTERDM Hospital & Healthcare Services | Mid Cap | Aster DM Quality Share Price
₹759.25 -8.80 (-1.15%)
As on 25-Sep'26 16:59
Aster DM Quality Care Ltd (ASTERDM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 540975 NSE: ASTERDM Hospital & Healthcare Services | Mid Cap | Aster DM Quality Share Price
₹759.25 -8.80 (-1.15%)
As on 25-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹66,182 Cr.
Current Price
₹759.3
52-Week Low / High
₹520 / 891
TTM EPS
₹3.7
TTM Sales
₹4,876 Cr.
Book Value per Share
₹48.5
P/E Ratio
207.67
Higher than its 5-year historical median
Industry PE
99.7
Price to Book (P/B)
15.65
Higher than its 5-year historical median
Price to Sales (P/S)
13.57
Higher than its 5-year historical median
EV/EBITDA
60.29
Higher than its 5-year historical median
Dividend Yield
0.4%
Profitability Efficiency
Return on Equity (ROE)
13.07%
Outperforms industry median
Return on Capital Employed (ROCE)
16.22%
Outperforms industry median
Return on Assets (ROA)
5.82%
Operating Profit Margin
19.7%
Net Profit Margin
9.2%
Gross Profit Margin
19.5%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
12.72%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
17.63%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
26.85%
Asset Quality
Promoter Holding
40.39%
Pledged shares (%) of Promoter's holding (%)
40.66%
Reserves
₹3,358 Cr.
Equity
₹871.7 Cr.
Face Value
₹10
All Time Low / High
₹78.50 / 890.95
Check Before You Invest
Quality
Somewhat GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Aster DM Quality Care Ltd a good quality company?
Aster DM Quality Care Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Aster DM Quality Care Ltd performance compare with that of its Peers?
Revenue growth of Aster DM Quality Care Ltd vs industry peers?
Aster DM Quality Care Ltd revenue CAGR is -11.61%, compared to the industry median CAGR of 25.04%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of Aster DM Quality Care Ltd?
Promoters hold 40.39% of the Aster DM Quality Care Ltd, with 40.66% of their stake pledged, indicating high pledge risk.
Stock return of Aster DM Quality Care Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 28.9% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aster DM Quality Care Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 9.4% | -1.1% | 1.9% | 3.2% | -1% | 4.4% | 7.3% | 8.3% | 175% | 11.3% | - |
| Value Creation Index ⓘ | -0.2 | -1.1 | -0.9 | -0.8 | -1.1 | -0.7 | -0.5 | -0.3 | 14.6 | 0 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 380 | 530 | 595 | 760 | 747 | 1,116 | 1,534 | 2,037 | 2,320 | 2,616 | 2,728 |
| Sales YoY Gr. | - | 39.7% | 12.2% | 27.9% | -1.8% | 49.6% | 37.4% | 32.8% | 13.9% | 12.7% | - |
| Adj EPS ⓘ | -5.4 | -1.7 | 0.9 | 1.2 | -1.2 | 1.8 | 3.5 | 3.2 | 119.7 | 6.4 | 2 |
| YoY Gr. | - | NA | NA | 28.7% | -196.7% | NA | 91.7% | -9.2% | 3698.7% | -94.7% | - |
| BVPS (₹) ⓘ | 57.4 | 57.6 | 58.7 | 58.8 | 57.4 | 59 | 54 | 57.2 | 58.1 | 75.7 | 48.9 |
| Adj Net Profit ⓘ | -218 | -86 | 47.5 | 60 | -58.3 | 90.3 | 173 | 157 | 5,977 | 332 | 173 |
| Cash Flow from Ops. ⓘ | -50.7 | -3 | -50.7 | 98 | 41.7 | 78.3 | 246 | 413 | 367 | 387 | - |
| Debt/CF from Ops. ⓘ | -12.7 | -37 | -2.5 | 1.5 | 4 | 2.5 | 1.4 | 0.9 | 1 | 0.8 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 23.9% | 28.5% | 19.5% | 12.7% | ||||
| Adj EPS ⓘ | NA | NA | 22.6% | -94.7% | ||||
| BVPSⓘ | 3.1% | 5.7% | 12% | 30.3% | ||||
| Share Price | - | 28.9% | 32.8% | 21.5% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | -13.3 | -3.3 | 1.6 | 2 | -2 | 3.1 | 5.7 | 4.9 | 180.2 | 8.6 | 3.2 |
| Op. Profit Mgn % ⓘ | -12.4 | 2.2 | 7 | 9.6 | 7.6 | 13.7 | 19.1 | 18 | 19.9 | 21.3 | 20.7 |
| Net Profit Mgn % ⓘ | -57.4 | -16.2 | 8 | 7.9 | -7.8 | 8.1 | 11.3 | 7.7 | 257.6 | 12.7 | 6.3 |
| Debt to Equity ⓘ | 0.3 | 0 | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | - |
| Working Cap Days ⓘ | 240 | 187 | 188 | 166 | 181 | 155 | 170 | 169 | 154 | 143 | 102 |
| Cash Conv. Cycle ⓘ | 17 | 13 | 14 | -8 | -31 | -27 | -23 | -21 | -21 | -23 | 65 |
Valuation of Aster DM Quality - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 98.87 | 98.87 | 98.87 | 98.87 | 40.67 | 40.67 | 40.66 | 40.66 | 40.66 | 40.66 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5,931 | 6,721 | 7,963 | 8,652 | 8,608 | 10,253 | 2,994 | 3,699 | 4,138 | 4,643 |
| Operating Expenses ⓘ + | 5,582 | 6,089 | 7,074 | 7,363 | 7,506 | 8,720 | 2,536 | 3,112 | 3,365 | 3,733 |
| Operating Profit ⓘ | 349 | 632 | 889 | 1,289 | 1,103 | 1,533 | 458 | 587 | 773 | 910 |
| Operating Profit Margin (%) | 5.9% | 9.4% | 11.2% | 14.9% | 12.8% | 15.0% | 15.3% | 15.9% | 18.7% | 19.6% |
| Other Income ⓘ + | 37 | 45 | 35 | 38 | 50 | 51 | 37 | 25 | 148 | 126 |
| Interest ⓘ | 371 | 204 | 205 | 391 | 334 | 307 | 96 | 119 | 133 | 132 |
| Depreciation ⓘ | 322 | 298 | 306 | 586 | 618 | 641 | 192 | 220 | 249 | 264 |
| Profit Before Tax ⓘ | 108 | 308 | 410 | 330 | 205 | 637 | 195 | 261 | 471 | 570 |
| Tax ⓘ | 11 | 26 | 43 | 15 | 27 | 36 | 36 | 57 | 134 | 143 |
| Profit After Tax | 98 | 282 | 367 | 315 | 178 | 601 | 160 | 205 | 337 | 427 |
| PAT Margin (%) | 1.6% | 4.2% | 4.6% | 3.6% | 2.1% | 5.9% | 5.3% | 5.5% | 8.1% | 9.2% |
| Adjusted EPS (₹) | 2.5 | 5.3 | 6.6 | 5.6 | 3.0 | 10.5 | 8.5 | 2.6 | 107.7 | 7.5 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 77.30% | 114.30% | 40.10% |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 1,875 | 2,832 | 3,214 | 3,272 | 3,372 | 3,953 | 4,442 | 4,552 | 3,419 | 4,562 | |
| Debt + | 2,721 | 2,212 | 2,608 | 2,479 | 1,914 | 1,757 | 1,813 | 1,790 | 509 | 573 | |
| Minority Interest | 375 | 358 | 466 | 446 | 462 | 529 | 412 | 470 | 223 | 258 | |
| Trade Payables | 782 | 846 | 1,014 | 2,110 | 2,027 | 2,118 | 2,988 | 3,436 | 426 | 482 | |
| Others Liabilities ⓘ | 1,050 | 1,231 | 1,627 | 4,097 | 3,844 | 4,164 | 5,181 | 7,735 | 2,023 | 2,202 | |
| Total Liabilities ⓘ | 6,804 | 7,479 | 8,928 | 12,405 | 11,620 | 12,521 | 14,836 | 17,983 | 6,600 | 8,076 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 3,520 | 3,738 | 4,289 | 7,124 | 6,749 | 7,009 | 9,052 | 3,175 | 3,920 | 4,242 | |
| CWIP ⓘ | 290 | 402 | 550 | 736 | 934 | 998 | 279 | 170 | 293 | 420 | |
| Investments ⓘ | 32 | 38 | 22 | 34 | 63 | 45 | 80 | 17 | 245 | 1,167 | |
| Inventories | 526 | 627 | 732 | 961 | 849 | 1,026 | 1,306 | 1,632 | 92 | 91 | |
| Trade Receivables | 1,288 | 1,546 | 2,029 | 2,366 | 2,019 | 2,021 | 2,336 | 2,440 | 258 | 307 | |
| Cash Equivalents | 152 | 300 | 341 | 177 | 281 | 380 | 429 | 2,550 | 1,380 | 1,325 | |
| Others Assets ⓘ | 997 | 828 | 965 | 1,007 | 725 | 1,044 | 1,354 | 7,998 | 412 | 524 | |
| Total Assets ⓘ | 6,804 | 7,479 | 8,928 | 12,405 | 11,620 | 12,521 | 14,836 | 17,983 | 6,600 | 8,076 | |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 361 | 537 | 601 | 1,223 | 1,569 | 1,314 | 1,834 | 158 | 425 | 656 |
| Cash Flow From Investing Activity ⓘ + | -1,153 | -523 | -709 | -667 | -330 | -570 | -972 | -885 | 6,015 | -288 |
| Cash Flow From Financing Activity ⓘ + | 654 | 46 | 134 | -675 | -1,116 | -686 | -817 | 1,053 | -6,358 | -304 |
| Net Cash Flow ⓘ | -138 | 61 | 26 | -119 | 123 | 58 | 45 | 326 | 82 | 63 |
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 8.5 | 11.97 | 12.15 | 9.7 | 5.35 | 16.41 | 3.98 | 4.97 | 9.8 | 13.07 |
| ROCE (%) | 11.45 | 10.43 | 11 | 11.77 | 9.03 | 15.96 | 4.52 | 5.76 | 11.85 | 16.22 |
| Asset Turnover Ratio | 0.95 | 0.94 | 0.97 | 0.81 | 0.72 | 0.85 | 0.22 | 0.23 | 0.34 | 0.63 |
| PAT to CFO Conversion(x) | 3.68 | 1.9 | 1.64 | 3.88 | 8.81 | 2.19 | 11.46 | 0.77 | 1.26 | 1.54 |
| Working Capital Days | ||||||||||
| Receivable Days | 80.90 | 77 | 81.90 | 92.70 | 93 | 71.90 | 265.60 | 235.70 | 119 | 22.20 |
| Inventory Days | 28.80 | 31.30 | 31.20 | 35.70 | 38.40 | 33.40 | 142.10 | 144.90 | 76 | 7.20 |
| Payable Days | 143.10 | 144.30 | 140.30 | 224.60 | 296.30 | 261.60 | 1,195.90 | 1,280 | 751.10 | 158 |
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Aster DM Quality Care Ltd FAQs
The current trading price of Aster DM Quality on 25-Sep-2026 16:59 is ₹759.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Sep-2026 the market cap of Aster DM Quality stood at ₹66,181.7 Cr
The latest P/E ratio of Aster DM Quality as of 24-Sep-2026 is 382.7.
The latest P/B ratio of Aster DM Quality as of 24-Sep-2026 is 15.52.
The 52-week high of Aster DM Quality is ₹891.0 and the 52-week low is ₹519.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aster DM Quality is ₹2,728 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Aster DM Quality Care Ltd is a average quality company.
The key valuation ratios of Aster DM Quality Care Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Aster DM Quality Care Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Aster DM Quality Care Ltd
The company was incorporated on January 18, 2008 as ‘DM Healthcare Private Limited’ at Kochi, Ernakulam, Kerala as a private limited company under the Companies Act, 1956. The name of company was changed to ‘Aster DM Healthcare Private Limited’ and a fresh certificate of incorporation consequent upon change of name was issued on November 29, 2013. Subsequently, the company was converted into a public company pursuant to special resolution passed by shareholders on November 10, 2014 and the name of the company was changed to ‘Aster DM Healthcare Limited’ a Fresh Certificate of Incorporation consequent upon conversion to public limited Company dated on January 1, 2015.
The company is one of the largest private healthcare service providers which operate in multiple GCC states based on numbers of hospitals and clinics. It currently operate in all of the GCC states, which comprise the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait and Bahrain, in Jordan, in India and the Philippines. Its GCC operations are headquartered in Dubai, United Arab Emirates and Indian operations are headquartered in Kochi, Kerala. The company has a diversified portfolio of healthcare facilities, consisting of 9 hospitals, 90 clinics and 206 retail pharmacies in the GCC states, 10 multi-specialty hospitals and 7 clinics in India, and 1 clinic in the Philippines as of September 30, 2017.
Business area of the company
The company operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC states through its various brands “Aster”, “Medcare” and “Access”. A majority of its hospitals and clinics provide secondary and tertiary healthcare services to patients. In addition to providing core medical, surgical and emergency services, some of its hospitals provide complex and advanced quaternary healthcare in various specialties, including cardiology, oncology, radiology, ophthalmology, neurosciences, paediatrics, gastroenterology, orthopaedics and critical care services.
Awards and achievements
- 2001: MIMS Hospital, Kozhikode, India received the first place (certificate of merit) from the Kerala State Pollution Control Board for making a substantial and sustained effort in pollution control. MIMS subsequently received this certificate of merit in 2007, 2008, 2009, 2010, 2011, 2012 and 2013 for various hospitals.
- 2006: MIMS Hospital, Kozhikode, India received NABH accreditation valid upto October 29, 2009 which was subsequently renewed up to October 29, 2018.
- 2012: MIMS Laboratory Services, MIMS received ISO 15189:2007 certification in the field of Medical Testing valid up to October 8, 2016, which was subsequently renewed as ISO 15189:2012 up to October 8, 2018.
- 2013: Medcare Hospital LLC, Dubai, UAE received JCI accreditation valid up to December 21, 2016, which was subsequently renewed up to November 10, 2019.
- 2014: Aster Pharmacy Group received the Best Service Performance Brand Award by Dubai Service Excellence Scheme.
- 2015: Aster Medcity, Kochi, India received NABH accreditation for compliance with the Certification Standards for Nursing Excellence valid up to March 30, 2017 which was subsequently renewed up to March 30, 2019.
- 2015: Aster Medcity, Kochi, India received the ISO 22000:2005 certification for production and service of food for patients, staff and patients’ relatives within the hospital from Bureau Veritas Certification Holding SAS – UK Branch, valid up to July 16, 2018.
- 2015: The company received the ‘National Awards for Excellence in Healthcare Award for Best Marketing Campaign – Healthcare Industry’ by CMO Asia.
- 2016: The company received the ‘Institutional Bravery Award’ for Distinguished Service in Flood Relief in Chennai and Cuddalore, 2015 by the Society for Emergency Medicine India.
- 2016: Aster Pharmacies Group received the Dubai Quality Appreciation Award for 2016 from the Government of Dubai.
- 2016: Aster Pharmacy received the Best Service Performance Brand Award by Dubai Service Excellence Scheme.
- 2017: Aster CMI hospital received the ‘Best Hospitality in Healthcare’ award from the Times Network.
- 2017: Aster CMI hospital has been ranked as the 23rd best multi specialty hospital (national rankings), 7th best multi specialty hospital (South India) and 2nd best multi specialty hospital in Bangalore in the All India Multispecialty Hospital Ranking Survey 2017 by the Times Group.
- 2017: Aster CMI hospital has been ranked 11th in gastroenterology and hepatology (South India) and 3rd in gastroenterology and hepatology in Bangalore in the All India Critical Care Hospital Ranking Survey 2017 by the Times Group.
- 2017: Aster CMI hospital has received the ‘CMO Asia Presents Asia Healthcare Excellence Award’ in the ‘best hospitality in healthcare’ category.
- 2018: Aster DM Healthcare wins Special Recognition at Arabia CSR Awards 2018.
- 2018: Aster Pharmacy & Aster Hospital win Dubai Business Excellence Awards.
- 2019: Aster DM Healthcare wins four Dubai Business Excellence Awards.
- 2019: Aster Volunteers CSR Award PR.
- 2019: Aster DM Healthcare bags Gulf Business Awards-2017 for the 'Healthcare Company of the Year' Category.
- 2020: Aster MIMS Kottakkal conferred Six Sigma Healthcare Excellence Award.
- 2020: Aster DM Healthcare wins 6 awards at AHPI Awards 2020
Major Events
- 1987: The company’s Promoter, Dr. Azad Moopen started a clinic in Dubai.
- 1995: First specialty medical centre was launched in Dubai.
- 2001: MIMS Kozhikode Hospital commenced operations.
- 2005: Al Rafa Hospital for Maternity and Surgery (now called Aster Day Surgery Centre LLC) commenced operations.
- 2006: Medcare Hospital, commenced operations.
- 2008: The company acquired majority stake in PHL, Kolhapur.
- 2009: Al Raffah Hospital, first hospital in Oman, commenced operations in Muscat.
- 2010: The company acquired 100% of the paid up equity share capital of Affinity, Mauritius.
- 2010: Al Raffah Hospital, second hospital in Oman, commenced operations in Sohar.
- 2011: Second Medcare Hospital, namely Medcare Orthopedics and Spine Hospital (Dubai) commenced operations.
- 2013: The company acquired 60.35% of the paid up equity share capital of IHPL and consequently MIMS became its Subsidiary.
- 2014: The company acquired hospital operational and management rights in Aster CMC, Bangalore pursuant to the hospital operation and management agreement dated May 12, 2014.
- 2014: The company acquired 54% stake in Aster Kuwait and 51% stake in Orange Pharmacies LLC, Jordan.
- 2015: First clinic in the Kingdom of Bahrain commenced operations; first clinic in the Philippines commenced operations.
- 2016: The company divested its stake in Medipoint Hospitals Private Limited, Pune.
- 2016: The company acquired 51% stake in Dr Ramesh Hospital.
- 2016: Second clinic in Bahrain commences operations.
- 2016: Medcare Women and Child Hospital in Dubai was launched.
- 2017: Entered into an operation and management agreement with the Rashtreeya Sikshana Samithi Trust to operate and manage a hospital in Bengaluru.
- 2017: Medare Hospital Sharjah and Aster Hospital Doha commenced operations.
- 2018: Aster DM Healthcare partners with Nigerian University Hospital to provide advanced healthcare solutions.
- 2018: Aster Pharmacy launches its First Eco-Friendly Pharmacy in UAE.
- 2018: Sharjah Health Authority signs MoU with Aster DM Healthcare to expand healthcare coverage for residents.
- 2019: Aster DM Healthcare hikes shareholding in Prerana Hospital to 86.99%.
- 2019: Aster DM Healthcare hikes stake in Sri Sainatha Multispeciality Hospital.
- 2020: Aster DM Healthcare collaborates with Social Alpha.
You have 45 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
